| Submit your comments on this article |
| Science & Technology |
| The risks of the first pill for postpartum depression |
| 2023-08-12 |
| [BBC] Zurzuvae, the first ever pill to treat postpartum depression is here. It’s faster, less invasive and has milder side effects than brexanolone, the only other FDA-approved treatment before it. How exactly does it work? And does it have side effects or risks? Sanjana Bhambhani interviewed the Chief of Columbia University's Division of Women’s Mental Health, Dr. Catherine Monk, to explore the concerns around this new drug. |
| Posted by:Besoeker |
| #9 |
| Posted by: Skidmark 2023-08-12 19:56 |
| #8 |
| Posted by: Super Hose 2023-08-12 12:35 |
| #7 |
| Posted by: M. Murcek 2023-08-12 12:06 |
| #6 |
| Posted by: swksvolFF 2023-08-12 11:53 |
| #5 |
| Posted by: DooDahMan 2023-08-12 10:05 |
| #4 |
| Posted by: SteveS 2023-08-12 09:48 |
| #3 |
| Posted by: M. Murcek 2023-08-12 09:27 |
| #2 |
| Posted by: DooDahMan 2023-08-12 08:58 |
| #1 |
| Posted by: Besoeker 2023-08-12 07:59 |